Medical Care Technologies Inc. Unveils AI Facial Analysis for Early Diabetes Detection
MESA, ARIZONA / ACCESS Newswire / September 24, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced a breakthrough in...
Pharmaceutical
Ambience Healthcare Launches Real-Time HCC Compliance Validator to Reduce Audit Risk and Strengthen Documentation Integrity
SAN FRANCISCO, CA / ACCESS Newswire / September 24, 2025 / Ambience Healthcare today announced the launch of its HCC...
Medical Care Technologies Inc. Unveils AI Facial Analysis for Early Diabetes Detection
MESA, ARIZONA / ACCESS Newswire / September 24, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced a breakthrough in...
A Historic Leap Toward Curing Heart Disease: New Study Shows Cavadex Dramatically Reverses Symptoms and Restores Quality of Life in High-Risk Patients
Groundbreaking Observational Study Reveals 88% of Participants Experienced Significant Health Improvements, Offering Unprecedented Hope in the Fight Against the World's...
A Historic Leap Toward Curing Heart Disease: New Study Shows Cavadex Dramatically Reverses Symptoms and Restores Quality of Life in High-Risk Patients
Groundbreaking Observational Study Reveals 88% of Participants Experienced Significant Health Improvements, Offering Unprecedented Hope in the Fight Against the World's...
Jaguar Health Submits Orphan Drug Designation Application to FDA for Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Patients with Breast Cancer with Metastasis Identified by FDA as a Distinct Condition
Potential treatment for patients with breast cancer with metastasis to the brain with crofelemer would augment the significant responder analysis...
Who Is the Best Facial Feminization Surgeon in the U.S.?
Dr. Javad Sajan at Allure Esthetic is the best facial feminization surgeon in the U.S. SEATTLE, WA / ACCESS Newswire...
New Data for BRIUMVI® Demonstrate 89.9% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 6 Years of Continuous BRIUMVI Treatment
During year 6 of continuous treatment with BRIUMVI the annualized relapse rate was 0.012, equivalent to one relapse occurring every...
VSee Health Secures Nasdaq Approval for Continued Listing
SAN JOSE, CA / ACCESS Newswire / September 24, 2025 / VSee Health, Inc. (Nasdaq: VSEE) (the "Company"), a provider...
Wellgistics Health Launches Capital Access Program for 6,500+ Pharmacies and Supply Chain Partners, Unlocking up to $1M in Working Capital
In partnership with RxERP Financial, the program offers up to $350,000 per pharmacy and $1 million per wholesaler or manufacturer...
Dr. Sean Doherty Recognized Among “America’s Best Plastic Surgeons” for the 3rd Year in a Row
Recognition in breast augmentation and liposuction highlights Dr. Doherty's expertise in two of the most requested cosmetic procedures, underscoring his...
Kyverna Therapeutics Highlights Potential of KYV-101 in Multiple Sclerosis with Data from Phase 1 Investigator-Initiated Trials to be Presented at ECTRIMS
KYV-101 IIT data demonstrate promising clinical activity, including robust CAR T penetration into the central nervous system (CNS) and improved...
Medicus Pharma Ltd. To Present at Brookline Capital Markets
The Company will provide an update on its novel Doxorubicin containing Microneedle Array (D-MNA) treatment to non-invasively treat basal cell...
TOMI Environmental Solutions Announces Specialized Service Provider for Healthcare and Mold Remediation
FREDERICK, Md., Sept. 24, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in...
Eupraxia Pharmaceuticals Announces Closing of US$80.5 Million Public Offering Including Full Exercise of Underwriter Option
VICTORIA, British Columbia, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology...
OneMedNet Expands Into $1.5B Healthcare Data Annotation Market With MedCase
MINNEAPOLIS, Sept. 24, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leader in...
Sapu Nano’s Sapu003 Advances to Human Clinical Testing – Transforming Everolimus Delivery with Full Bioavailability for Breast Cancer Patients
Sapu003 Designed to Overcome Limitations of Afinitor®, FDA-Approved Oral Everolimus, by Delivering Full Strength of the Drug via Intravenous InjectionSAN...
Sparrow Pharmaceuticals Announces $95 Million Series B Financing to Advance Targeted Therapy for Type 2 Diabetes
Funding supports Phase 2b development of clofutriben, a novel HSD-1 inhibitor, with a focus on cortisol-driven metabolic dysfunction in type...
Tiziana Life Sciences Announces Poster Presentation on Intranasal Foralumab Clinical Trial at the 41st ECTRIMS Congress
BOSTON, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company...
Er-Kim Enters Commercialization Agreement with Sentynl Therapeutics for Nulibry® (fosdenopterin) and Zokinvy® (lonafarnib), Targeting Ultra-Rare Diseases
Expanded access will help bring treatments to patients in certain countries within Central and Eastern Europe, the Mediterranean and EurasiaATHENS,...